Editorial: Unraveling inflammatory pathways in sickle cell disease: molecular, cellular and translational insights. [PDF]
Conran N, Chakravorty S, Sesti-Costa R.
europepmc +1 more source
Changes in haematological indices among children with sickle cell disease on hydroxyurea treatment for at least 1 year: A cohort study. [PDF]
Emuli S +11 more
europepmc +1 more source
The role of hydroxyurea in modulating miRNA expression in sickle cell disease: molecular mechanisms and therapeutic implications. [PDF]
Mirzaee F +3 more
europepmc +1 more source
Hydroxyurea Therapy in Sickle Cell Disease: Evaluating Healthcare Costs and Utilization in a Brazilian Tertiary Setting. [PDF]
Browne LLA +9 more
europepmc +1 more source
Tofacitinib Use in a Patient With Rheumatoid Arthritis and Polycythemia Vera: A Case Report. [PDF]
Bogojevic M +4 more
europepmc +1 more source
Rethinking Sickle Cell Disease as a Systemic Vasculopathy. [PDF]
DuPont M +4 more
europepmc +1 more source
Advances and Gaps in Global Newborn Screening for Sickle Cell Disease. [PDF]
Shook LM, Ware RE.
europepmc +1 more source

